Literature DB >> 10992296

Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.

A Gemma1, M Seike, Y Seike, K Uematsu, S Hibino, F Kurimoto, A Yoshimura, M Shibuya, C C Harris, S Kudoh.   

Abstract

Mutations in mitotic checkpoint genes have been detected in several human cancers, and these cancers exhibit chromosomal instability. Aneuploid stem cells seem to result from chromosomal instability and have been reported in many lung cancers. To determine whether alteration of mitotic checkpoint regulators is involved in carcinogenesis and tumor progression in primary lung cancer, we screened the genomic DNA sequence of 30 human lung cancer cell lines and 30 primary lung cancer tumors for a mutation in the hBUB1 mitotic checkpoint gene. First, we designed 26 sets of intron-based primers to amplify each of the 25 exons of the hBUB1 gene to examine the entire coding region of the hBUB1 gene. Using these primers, we performed polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis as well as direct sequencing in the mutation analysis of the hBUB1 gene. Three different nucleotide substitutions were detected in the coding region of the hBUB1 gene in some of the cancer cell lines and primary tumors as follows. The hBUB1 gene of one adenocarcinoma tumor contained a somatic missense mutation, a cytosine-to-guanine substitution in codon 51 of exon 5 that resulted in a histidine-to-aspartic acid amino acid substitution. The hBUB1 gene of three lung cancer cell lines contained a thymine-to-cytosine substitution in codon 430 of exon 12, which did not result in an amino-acid substitution. We were unable to determine whether the nucleotide substitution in exon 12 was a polymorphism or a silent mutation because matched normal tissue was not available. A polymorphism in codon 93 of exon 4, a guanine-to-thymine substitution, in hBUB1 was found in one lung cancer cell line and one primary lung tumor. This is the first report of a somatic missense mutation of a gene involved in a mitotic checkpoint in primary lung cancer. The presence of a point mutation in the hBUB1 gene is consistent with the hypothesis that alteration of mitotic checkpoint genes is involved in the development of primary lung cancers. Because the frequency of hBUB1 gene mutations was low, future studies should focus on other mechanisms of inactivation of the hBUB1 gene as well as mutation analysis of other mitotic checkpoint genes in lung cancers. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992296     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1027>3.0.co;2-g

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  22 in total

Review 1.  Mitotic checkpoint defects: en route to cancer and drug resistance.

Authors:  Sinjini Sarkar; Pranab Kumar Sahoo; Sutapa Mahata; Ranita Pal; Dipanwita Ghosh; Tanuma Mistry; Sushmita Ghosh; Tanmoy Bera; Vilas D Nasare
Journal:  Chromosome Res       Date:  2021-01-06       Impact factor: 5.239

Review 2.  Cell-cycle Checkpoints and Aneuploidy on the Path to Cancer.

Authors:  Elizabeth S Wenzel; Amareshwar T K Singh
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

Review 3.  Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation.

Authors:  Robin M Ricke; Jan M van Deursen
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

4.  Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.

Authors:  Michael J Bond; Marina Bleiler; Lauren E Harrison; Eric W Scocchera; Masako Nakanishi; Narendran G-Dayanan; Santosh Keshipeddy; Daniel W Rosenberg; Dennis L Wright; Charles Giardina
Journal:  Mol Cancer Res       Date:  2018-05-16       Impact factor: 5.852

5.  Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias.

Authors:  Naoyuki Homma; Gen Tamura; Teiichiro Honda; Zhe Jin; Kiyonari Ohmura; Sumio Kawata; Teiichi Motoyama
Journal:  Virchows Arch       Date:  2004-12-10       Impact factor: 4.064

6.  The optimal rate of chromosome loss for the inactivation of tumor suppressor genes in cancer.

Authors:  Natalia L Komarova; Dominik Wodarz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-22       Impact factor: 11.205

7.  Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.

Authors:  Zheng Fu; Kevin Regan; Lizhi Zhang; Michael H Muders; Stephen N Thibodeau; Amy French; Yanhong Wu; Scott H Kaufmann; Wilma L Lingle; Junjie Chen; Donald J Tindall
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

Review 8.  Mitotic chromosomal instability and cancer: mouse modelling of the human disease.

Authors:  Juan-Manuel Schvartzman; Rocio Sotillo; Robert Benezra
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

9.  The crystal structure of the N-terminal region of BUB1 provides insight into the mechanism of BUB1 recruitment to kinetochores.

Authors:  Victor M Bolanos-Garcia; Tomomi Kiyomitsu; Sheena D'Arcy; Dimitri Y Chirgadze; J Günter Grossmann; Dijana Matak-Vinkovic; Ashok R Venkitaraman; Mitsuhiro Yanagida; Carol V Robinson; Tom L Blundell
Journal:  Structure       Date:  2009-01-14       Impact factor: 5.006

10.  Bub1 regulates chromosome segregation in a kinetochore-independent manner.

Authors:  Christiane Klebig; Dirk Korinth; Patrick Meraldi
Journal:  J Cell Biol       Date:  2009-06-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.